Auto giant Hyundai Motor Co announced that it named José Muñoz as the new global Chief Operating Officer.
In an official announcement by the company, Hyundai said that Muñoz would oversee global operations strategies and their implementation. “His focus will be to deliver profitable growth and to improve overall performance of Hyundai Motor based on his decades of automotive and technology experience.” read the statement from the company.
Apart from the new COO post, Muñoz was also named the President and CEO of both Hyundai Motor North America and Hyundai Motor America.
Hyundai Motor Co President Wonhee Lee said, “José Muñoz has an impressive track record and is proven to be a visionary and motivational leader who is adept at all aspects of our business…”
“His decades of automotive and technology experience make him well suited for this new role as we move the company to the next step. We are looking forward to Mr. Muñoz joining the team, and will lean on his leadership skills and vision to achieve long-term sustainable growth and evolve into a Smart Mobility Solutions Provider.” the Hyundai President added.
As COO, Muñoz would report to Hyundai Motor Company’s top leadership in Seoul. He is expected to start on May 1 and be based in Fountain Valley, California.
Muñoz would be responsible for the entire American market, including Hyundai Motor North, Central and South America — as the Head of Hyundai Motor Americas Region.
Muñoz was most recently the Chief Performance Officer for Nissan Motor Corp and the Chairman of Nissan China. He joined Nissan in 2004 and during his 15 years at the automaker led significant growth and record sales in the regions he managed.
Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on